Journals / MN Kardiyoloji / 2002 / Cilt: 9 - Sayı: 4

No-reflow phenomenon developed in non-target vessel during balloon angioplasty

Balon anjiyoplasti sırasında hedef damar dışında "No-reflow" fenomeni gelişen bir olgu

Pages
281–282
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this report, interestingly, we present a case with no-reflow phenomenon occurred in another vessel in addition to the target vessel and successfully treated by verapamil.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:No-reflow phenomenon accepted to be occurred by mediators can cause TIMI 0 or 1 flow in the target vessel after coronary artery intervention and increase the number of complications.
📊
Key Findings & Data:No-reflow phenomenon accepted to be occurred by mediators can cause TIMI 0 or 1 flow in the target vessel after coronary artery intervention and increase the number of complications.
💡
Conclusion & Impact:In this report, interestingly, we present a case with no-reflow phenomenon occurred in another vessel in addition to the target vessel and successfully treated by verapamil.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Verapamil · Anjiyoplasti · transluminal

Abstract

No-reflow phenomenon accepted to be occurred by mediators can cause TIMI 0 or 1 flow in the target vessel after coronary artery intervention and increase the number of complications. In this report, interestingly, we present a case with no-reflow phenomenon occurred in another vessel in addition to the target vessel and successfully treated by verapamil.

Özet

Mediatörler aracılığıyla ortaya çıktığı kabul edilen "no-reflow" fenomeni koroner arter girişimleri sonrasında hedef damarda TIMI 0 veya 1 akıma neden olmakta ve işlem komplikasyonlarını artırmaktadır. Bu yazıda ilginç olarak hedef damar dışında başka damarda da ortaya çıkan ve verapamil ile tedavi edilen bir "no-reflow" fenomeni olgusu sunulmaktadır.

🔖

Cite This Article

KURŞAKLIOĞLU, H., İYİSOY, A., BARÇIN, C., KÖSE, S., DEMİRTAŞ, E. (2002). No-reflow phenomenon developed in non-target vessel during balloon angioplasty. MN Kardiyoloji, Cilt: 9 - Sayı: 4, 281–282. https://ajindex.com/articles/297708

References (6)

  1. Abbo KM, Dooris M, Glazier S et al: Features and outcomes of no-reflow after percutaneous coronary interventions. Am J Cardiol 1995; 75:778-82
  2. Piana RN, Paik GY, Moscucci M et al: Incidence and treatment of "no-reflow" after percutaneous coronary intervention. Circulation 1994; 89:2514-8
  3. Hayerizadeh BF, Marco J: Diagnosis and management of acute complications of coronary interventions In: Marco J, Serruys P, Biamino G, Fajadet J, Feyter P, Morice MC Eds. The Paris Course on Revascularization. Paris, 2001
  4. Hillegas WB, Dean NA, Liao L, Rhinehart RG, Myers PR: Treatment of no-reflow and impaired flow with the nitric oxide donor nitroprusside following percutaneous coronary interventions: initial human clinical experience. J Am Coll Cardiol 2001; 37:1335-43
  5. Pomerantz RM, Kuntz RE, Diver DJ et al: Intracoronary verapamil for the treatment of distal microvascular spasm following PTCA. Cath Cardiovasc Diagn 1991; 24:283-8
  6. Dillon WC, Hadian D, Ritchie ME: Refractory no-reflow successfully treated with local infusion of high dose adenosine and verapamil. Angiology 2001; 52:137-41